- Home
- BH vs RCKT Comparison
BH vs RCKT Comparison
Compare BH & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BH
- RCKT
- Stock Information
- Founded
- BH 1934
- RCKT 1999
- Country
- BH United States
- RCKT United States
- Employees
- BH N/A
- RCKT N/A
- Industry
- BH Restaurants
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- BH Consumer Discretionary
- RCKT Health Care
- Exchange
- BH Nasdaq
- RCKT Nasdaq
- Market Cap
- BH 681.4M
- RCKT 764.5M
- IPO Year
- BH N/A
- RCKT N/A
- Fundamental
- Price
- BH $240.16
- RCKT $6.99
- Analyst Decision
- BH
- RCKT Strong Buy
- Analyst Count
- BH 0
- RCKT 10
- Target Price
- BH N/A
- RCKT $42.00
- AVG Volume (30 Days)
- BH 10.1K
- RCKT 3.2M
- Earning Date
- BH 05-09-2025
- RCKT 05-08-2025
- Dividend Yield
- BH N/A
- RCKT N/A
- EPS Growth
- BH N/A
- RCKT N/A
- EPS
- BH N/A
- RCKT N/A
- Revenue
- BH $367,698,000.00
- RCKT N/A
- Revenue This Year
- BH N/A
- RCKT N/A
- Revenue Next Year
- BH N/A
- RCKT N/A
- P/E Ratio
- BH N/A
- RCKT N/A
- Revenue Growth
- BH 0.85
- RCKT N/A
- 52 Week Low
- BH $159.69
- RCKT $4.55
- 52 Week High
- BH $271.35
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- BH 62.95
- RCKT 48.90
- Support Level
- BH $222.54
- RCKT $6.21
- Resistance Level
- BH $247.04
- RCKT $8.26
- Average True Range (ATR)
- BH 8.60
- RCKT 0.54
- MACD
- BH 1.86
- RCKT 0.03
- Stochastic Oscillator
- BH 82.04
- RCKT 38.05
About BH Biglari Holdings Inc. Class B
Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, Oil and Gas Operations. Company's restaurant operations include Steak n Shake and Western Sizzlin. Its insurance operations include First Guard, Southern Pioneer, and Biglari Reinsurance. Oil and gas operations include Southern Oil and Abraxas Petroleum. The Company also reports segment information for Maxim. The majority of revenue is derived from the Maxim Segment.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.